In recent years, with the Chinese government’s increasing policy support for “new infrastructure” and the growing maturity of healthcare digitalization, China’s digital healthcare sector has entered a new stage of development. The COVID-19 pandemic has further accelerated the integration of various cutting-edge technologies with healthcare, allowing the public to fully experience the convenience of smart healthcare. As multiple technologies—including big data, 5G, cloud platforms, cloud computing, the Internet of Things (IoT), and artificial intelligence (AI)—continue to converge and innovate, and as cross-disciplinary collaboration expands across terminals, platforms, and applications, the smart healthcare sector is poised for more systematic and comprehensive growth.
It is precisely due to strong policy support and the rapid development of new technologies, which continuously empower the digital upgrading of medical processes, that collaborative achievements among enterprises are being increasingly implemented both within and outside hospitals.
Pharmaceutical companies such as Hengrui Medicine, Chia Tai Tianqing, Fosun Pharma, BeiGene, and Junshi Biosciences are actively leveraging digitalization to enhance their core competitiveness through strategic partnerships. Hengrui Medicine has collaborated with Zhenyun Technology to build an intelligent digital procurement management platform, improving the efficiency of its supply chain management; Chia Tai Tianqing Pharmaceutical Group has partnered with Medlinker to focus on developing a personalized internet healthcare management platform...
Cross-industry giants such as JD.com, Alibaba Health, Tencent, Huawei, Baidu, Meituan, and ByteDance are also exploring new models of healthcare services within the framework of “New Infrastructure.” Alibaba Health has partnered with Herui Gene to create an innovative, inclusive healthcare service model for early cancer screening, centered on an “internet platform + early cancer screening technology + medical security” framework. JD Health has entered into a strategic partnership with Ji’ai Medical to explore a new “physician group + internet” model. Meanwhile, Baidu is collaborating with Miao Health to develop a new AI-powered family doctor service model...
Numerous medical innovation enterprises are continuously expanding their markets through digitalization. DXY and vaccine giants such as Merck & Co. have jointly established a vaccine service platform, formally entering the “Internet + Vaccines” sector; LinkDoc Technology has partnered with AstraZeneca to co-develop innovative digital therapeutic products, thereby diversifying its product portfolio; Keya Medical, the first company to obtain a Class III medical device certificate for AI-based medical devices, has collaborated with Zhixin Medical to distribute its products nationwide across China...
Hospitals are also actively seeking collaborations, committed to providing higher-quality services to patients. Beijing Tiantan Hospital, the Chinese PLA General Hospital, and BioMind jointly launched an AI-based qualitative auxiliary diagnostic system for CT imaging of “COVID-19” pneumonia, reducing patients’ waiting times and their risk of infection during the pandemic. Shanghai Children’s Hospital and Huawei established a Joint Innovation Laboratory for 5G+ Medical Applications, applying information technology to enhance hospital services and research capabilities, thereby improving service efficiency and quality.
To gain a more comprehensive understanding of the development of digital health and to analyze the current state of digital innovation within China’s healthcare industry, as well as to explore future models of innovation, VCBeat VB100 is now calling for outstanding industry collaboration case studies in digital health from healthcare and medical innovation enterprises.
The case collection campaign launched on June 20 and will close on July 20. Dozens of medical innovation enterprises have already registered, and sign-ups are currently in full swing.。

The case solicitation campaign is primarily targeted at enterprises in the technology-driven healthcare sector, focusing on those that leverage digital innovations—such as the internet, artificial intelligence (AI), the Internet of Things (IoT), and 5G—to empower the digital transformation of medical processes, build hospital information systems, upgrade medical equipment digitally, improve business processes for healthcare companies, and enhance products and services.
For the numerous products and services in the field of technology-driven healthcare, VCBeat VB100 categorizes the implementation scenarios of digital health products and services into in-hospital and out-of-hospital settings, thereby defining the scope of submissions.
In-hospital scenarios, including but not limited to healthcare informatics, AI-based medical imaging, Clinical Decision Support Systems (CDSS), intelligent prescription, surgical robots, indoor hospital navigation, and smart nursing.
Out-of-Hospital Settings, including but not limited to medical services, pharmaceutical and medical device services, and health insurance services, such as internet hospitals, digital therapeutics, chronic disease management, construction of pharmaceutical distribution platforms, CRO/CMO, wearable devices, and public/commercial health insurance management services.
1. Enterprises participating in the call for outstanding case studies will receive two tickets to the “2021 China Digital Health Ecosystem Conference,” enabling more in-depth exchanges with professionals from government, industry peers, and potential partners.
2. Opportunity to deliver keynote addresses at the conference. In accordance with the overall conference plan, selected representatives from companies providing outstanding case studies may present their insights on the digital healthcare ecosystem to professional attendees, tailored to their unique strengths. Through on-site presentations and promotional coverage across VCBeat’s official website, official WeChat account, and media matrix, these speakers can achieve millions of impressions, thereby fostering multi-dimensional collaboration opportunities.
3. Outstanding case study enterprises will have the opportunity to be invited to attend the award ceremony and this Ecosystem Conference, sharing the stage with numerous other distinguished companies and engaging in face-to-face exchanges with industry peers to spark potential collaborations.
1. Registration Period and Method: June 20, 2021 – July 20, 2021
Register by scanning the QR code below or clicking the link. It is recommended to complete the registration and provide information on corporate medical technology projects using a computer.
2. Selection Period: July 21–28, 2021
Industry experts evaluate pre-screened, high-potential medical technology projects and select outstanding award-winning cases based on four criteria: product/service overview, business model, case innovation, and case outcomes.
3. Award Ceremony: August 14, 2021
Representatives from exemplary enterprises will attend the “2021 Digital Health Ecosystem Conference” to receive awards and will have the opportunity to deliver keynote speeches.
Scan the QR code below or click the link below to fill out the registration form. (It is recommended to complete the form on a computer.)

Registration Link:http://vcbeat-vb100.mikecrm.com/BTvJOn3
This case solicitation campaign will serve as a key component of the “2021 China Digital Health Ecosystem Conference.” VCBeat will invite representatives from select outstanding case-study companies to participate in the conference. Centered on the implementation of digital health solutions both within and outside hospital settings, the event will demonstrate its professional caliber through three pillars—conference sessions, exhibitions, and networking—while jointly exploring how new technologies and business models can shape a new digital health ecosystem.
Digital Health Ecosystem Conference: Industry Leaders Discuss Trends
The 2021 China Digital Healthcare Ecosystem Conference was held on August 14, 2021, at the China National Convention Center in Beijing. Co-hosted by the International Exchange and Cooperation Center of the National Health Commission and VCBeat VB100, the conference invited government officials, industry associations, hospital presidents, and leading enterprises to share insights and engage in dialogue on future trends and market opportunities in the healthcare ecosystem from the perspectives of policy, technology, and business models. The discussions focused on the extensive application of next-generation information technologies in the healthcare sector and the emergence of innovative service models, aiming to create a new healthcare ecosystem where medical care, health insurance, pharmaceuticals, and general health are empowered by new technologies.
Concurrent Exhibition on a Grand Scale: 6,000+ Professional Attendees Engage in Precise Market Exchange
The 29th International Medical Equipment Exhibition (China-Hospeq 2021)& Held concurrently and at the same venue as the 2021 Beijing Health Conference, the exhibition attracted over 6,000 professional attendees, including representatives from health commissions of provinces and municipalities across China, delegates from foreign consulates in China, and executives from major medical institutions. Distinguished guests included leaders from the National Health Commission, the Ministry of Industry and Information Technology, the National Medical Products Administration, the Ministry of Foreign Affairs, and the Ministry of Commerce. During the exhibition, teams from health departments of more than 20 provinces, autonomous regions, and municipalities were dispatched to conduct procurement research. The attendee roster comprised over 1,000 leaders from relevant ministries and commissions, health administrative officials, and heads of medical institutions; more than 3,000 hospital presidents and healthcare management professionals from all levels across China; representatives from over 50 countries stationed in China; more than 1,500 medical imaging specialists; over 600 critical care medicine professionals; and representatives from various health industry sectors.
Call for Excellent Case Studies: A Multidimensional Showcase of Collaborative Successes to Exemplify Best Practices
Through the call for outstanding collaborative case studies in digital health, this initiative aims to identify a selection of exemplary partnerships across various subsectors of digital health that demonstrate technological advancement and prominent demonstrative impact. It seeks to provide an in-depth analysis of the current state of digital innovation in China’s healthcare industry and explore future models of innovation. An awards ceremony will be held concurrently with the conference to honor the selected outstanding case studies. Participation in the conference and awards ceremony offers senior executives the opportunity to engage in face-to-face exchanges with numerous leading enterprises present, thereby providing new perspectives for corporate development.
Contact Us
